Skip to content
DataLookout
Menu

NCT07006389

Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 4 entries
    • Trial status changed: Enrolling by Invitation → Completed
    • Enrollment target: estimated 128 to confirmed 124
    • Study completion date changed from estimate of Jul 1, 2025 to Jul 15, 2025
    • Secondary endpoints: details revised at 2 of 4 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Calcaneal inclination angle
Timeframe: Day 1
Ankle dorsiflexion degree
Timeframe: Day 1
Plantar fascia thickness
Timeframe: Day 1
Tibial/plantar nerve conduction study with electroneuromyography
Timeframe: Day 1

Secondary (4)

Meary angle
Plantar calcaneal spurs
Heel Tenderness index
Foot Function Index

Arms and interventions

Non-responder group to ESWT

Patients who had less than 50% response in the Visual Analog Scale (VAS) after ESWT and patients who had \>50% VAS regression in the first month after ESWT and whose pain recurred afterwards

Responder group to ESWT

Patients who had \>50% VAS regression in the 6th month were included in the group that responded to ESWT treatment.

Sites

1 site in 1 country

  • Şişli Hamidiye Etfal Training and Research HospitalIstanbul, Turkey (Türkiye)